Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole

Clinical trial NCT05163106 · COMPLETED

Trial details

NCT number: NCT05163106
Sponsor: University Hospital, Akershus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-negative Breast Cancer ER-positive Breast Cancer Locally Advanced Breast Cancer Luminal A Breast Cancer Luminal B Breast Cancer

Start date: 2022-12-01
Primary completion: 2024-07-30
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.